Legend Biotech Co. (NASDAQ:LEGN) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eleven brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month […]
Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eleven brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month […]
